Semalytix Blog Semalytix’ and Boehringer Ingelheim’s innovative social media study on the parental experience around Crohn’s disease wins EphMRA award

A patient preference study of Crohn’s disease treatments, carried out by Semalytix and partner Boehringer Ingelheim, has won a European Pharmaceutical Market Researchers Association (EphMRA) market research excellence award[1]. The study was carried out together with Ben Collins (Semantic Analytics Manager, BI) and Wael Ayad (Sr. International Customer Insights Manager, BI).